Overall survival predictors in hepatocellular carcinoma patients treated with sorafenib
SUMMARY Malignant liver tumors are the fourth leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) accounts for 75-85% of these. Most patients are diagnosed at incurable stages. Palliative care is the appropriate treatment course in these circumstances (chemoembolization and soraf...
Main Authors: | Caroline Petersen da Costa Ferreira, Mauricio Alves Ribeiro, Luiz Arnaldo Szutan |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Médica Brasileira
|
Series: | Revista da Associação Médica Brasileira |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000300275&lng=en&tlng=en |
Similar Items
-
New challenges in clinical research on hepatocellular carcinoma
by: Álvaro Díaz-González, et al. -
Avaliação da ressecção hepática em pacientes cirróticos com carcinoma hepatocelular Evaluation of hepatic resection for hepatocellular carcinoma on cirrhotic livers
by: Maurício Silva, et al.
Published: (2008-06-01) -
Hemoperitoneum secondary to rupture of hepatocellular carcinoma
by: Yeney Espinosa Rodríguez, et al.
Published: (2021-07-01) -
Multiple factors affect the regeneration of liver
by: Gaoxiong Ouyang, et al. -
Microvascular invasion in hepatocellular carcinoma: is it predictable with quantitative computed tomography parameters?
by: Daniel Lahan-Martins, et al.